Pharmacokinetics and Tolerancebility Studies of Gentuximab Injection in the Treatment ofPatients With Late Recurrence of Metastatic Solid Tumors in China
NCT03313219
Changchun GeneScience Pharmaceutical Co., Ltd.Solid Tumor
Start: 2017-10-11End: 2019-12-31Target: 20Updated: 2017-12-12